Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
19.14
+0.09 (0.47%)
Apr 2, 2026, 4:00 PM EDT - Market closed
Legend Biotech Employees
Legend Biotech had 2,965 employees as of December 31, 2025. The number of employees increased by 356 or 13.65% compared to the previous year.
Employees
2,965
Change (1Y)
356
Growth (1Y)
13.65%
Revenue / Employee
$347,015
Profits / Employee
-$100,101
Market Cap
3.54B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,965 | 356 | 13.65% |
| Dec 31, 2024 | 2,609 | 783 | 42.88% |
| Dec 31, 2023 | 1,826 | 436 | 31.37% |
| Dec 31, 2022 | 1,390 | 319 | 29.79% |
| Dec 31, 2021 | 1,071 | 189 | 21.43% |
| Dec 31, 2020 | 882 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Crinetics Pharmaceuticals | 594 |
| Denali Therapeutics | 503 |
| Structure Therapeutics | 220 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 146 |
| Spyre Therapeutics | 102 |
LEGN News
- 25 days ago - Legend Biotech Corporation (LEGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Legend Biotech Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights - GlobeNewsWire
- 4 weeks ago - Artisan International Small-Mid Fund Q4 2025 Performance Review - Seeking Alpha
- 5 weeks ago - Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 2 months ago - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance - Seeking Alpha
- 2 months ago - Legend Biotech Corporation (LEGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
- 4 months ago - Cancer Study Buoys These Small Biotechs - Barrons